Home > Financial Ratios > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Working Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2017Mar2016
   Working Capital/Sales(x) 1.573.273.576.677.14

What is the latest Working Capital/Sales ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Working Capital/Sales ratio of SYNCOM FORMULATIONS (INDIA) is 1.57 based on Mar2024 Consolidated results.
Year Working Capital/Sales
Mar20241.57
Mar20233.27
Mar20223.57
Mar20176.67
Mar20167.14

How is Working Capital/Sales of SYNCOM FORMULATIONS (INDIA) Trending?

Years Working Capital/Sales % Change
Mar2024 1.57
-51.99
Mar2023 3.27
-8.40
Mar2022 3.57
-46.48
Mar2017 6.67
-6.58
Mar2016 7.14 -

Other Financial Ratios of SYNCOM FORMULATIONS (INDIA)


Compare Working Capital/Sales ratio of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,719.3 Cr 1.2% -3.1% 14.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹380,702.0 Cr -3.3% -4.6% -7.9% Stock Analytics
DIVIS LABORATORIES ₹156,908.0 Cr -9% -13.6% 24% Stock Analytics
TORRENT PHARMACEUTICALS ₹120,896.0 Cr -1.1% 7% 8.2% Stock Analytics
CIPLA ₹119,988.0 Cr -2% 0.6% -4% Stock Analytics
DR REDDYS LABORATORIES ₹101,122.0 Cr -1.1% -3.8% -13.3% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

1.2%

-3.1%

14.1%

SENSEX

-0.9%

-4.4%

1.6%


You may also like the below Video Courses